Searching for the liability to schizophrenia: Concepts and methods underlying genetic high-risk studies of adolescents

Journal of Child and Adolescent Psychopharmacology

Volumn 15, Issue 3, 2005, Pages 403-417

  Stone, William S ^a,b,f   Faraone, Stephen V ^e   Seidman, Larry J ^a,b,c   Olson, Elizabeth A ^a   Tsuang, Ming T ^a,b,d  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

^b HARVARD UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENCE; ADOLESCENT; AGGRESSION; ANTISOCIAL BEHAVIOR; BRAIN FUNCTION; COGNITIVE DEFECT; DEVELOPMENTAL DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FAMILY HISTORY; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; JUVENILE DELINQUENCY; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC TEST; PSYCHOSIS; PSYCHOSOCIAL WITHDRAWAL; REVIEW; SCHIZOPHRENIA; SCHIZOTAXIA; SCHIZOTYPAL PERSONALITY DISORDER; SYMPTOMATOLOGY; TEMPORAL LOBE; THALAMUS;

ADOLESCENT; BRAIN; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; SCHIZOPHRENIA;

EID: 23944508495     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2005.15.403     Document Type: Review

References (102)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
2. Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS). Iowa City (Iowa), The University of Iowa, 1983.
3. Asarnow J: Children at risk for schizophrenia: Converging lines of evidence. Schizophr Bull 14(4): 613-631, 1988.
4. Asarnow JR, Goldstein MJ: Schizophrenia during adolescence and early adulthood: A developmental perspective on risk research. Clin Psychol Rev 6:211-235, 1986.
5. Asarnow JR, Steffy RA, Mac Crimmon DJ, Cleghorn JM: An attentional assessment of foster children at risk for schizophrenia. In: The Nature of Schizophrenia: New Approaches to Research and Treatment. Edited by Wynne LC, Cromwell RL, Matthysse S. New York, John Wiley & Sons, 1978, pp 339-358.
6. Auerbach J, Hans S, Marcus J: Neurobehavioral functioning and social behavior of children at risk for schizophrenia. Isr J Psychiatry Relat Sci 30(1):40-49, 1993.
7. Battaglia M, Bernardeschi L, Franchini L, Bellodi L, Smeraldi E: A family study of schizotypal disorder. Schizophr Bull 21:33-45, 1995.
8. Battaglia M, Torgersen S: Schizotypal disorder: At the crossroads of genetics and nosology. Acta Psychiatr Scand 94:303-310, 1996.
9. Blackwood DH, Glabus MF, Dunan J, O'Carroll RE, Muir WJ, Ebmeier KP: Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia. Correlations with memory and P300. Br J Psychiatry 175:357-366, 1999.
10. Bleuler E: Dementia Praecox or the Group of Schizophrenias. New York: International Universities Press, 1911/1950.
11. Bolinskey K, Gottesman II, Nichols D, Shapiro B, Roberts S, Adamo U, Erlenmeyer-Kimling L: A new MMPI-derived indicator of liability to develop schizophrenia: Evidence from the New York High-Risk Project. Assessment 8:127-143, 2001.
12. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH: Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 58(11):1032-1037, 2001a.
13. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH: Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 15(4):411-420, 2001b.
14. Byrne M, Hodges A, Grant E, Owens DC, Johnstone EC: Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: Preliminary findings of the Edinburgh High-Risk Study (EHRS). Psychol Med 29:1161-1173, 1999.
15. Cannon TD, Mednick SA, Parnas J, Schulsinger F, Praestholm J, Vestergaard A: Developmental brain abnormalities in the offspring of schizophrenic mothers. I. Contributions of genetic and perinatal factors. Arch Gen Psychiatry 50:551-564, 1993.
16. Cornblatt B, Obuchowski M: Update of high-risk research: 1987-1997. Int Rev Psychiatry 9:437-447, 1997.
17. Cornblatt BA, Lenxenweger MF, Dworkin RH, Erlenmeyer-Kimling L: Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia. Br J Psychiatry 161(Suppl 18):59-64, 1992.
18. Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L: The Continuous Performance Test, Identical Pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res 26:223-238, 1988.
19. Cosway R, Byrne M, Clafferty R, Hodges A, Grant E, Abukmeil SS, Lawrie SM, Miller P, Johnstone EC: Neuropsychological change in young people at high risk for schizophrenia: Results from the first two neuropsychological assessments of the Edinburgh High-Risk Study. Psychol Med 30(5): 1111-1121, 2000.
20. Cosway R, Byrne M, Clafferty R, Hodges A, Grant E, Morris J, Abukmeil SS, Lawrie SM, Miller P, Owens DG, Johnstone EC: Sustained attention in young people at high risk for schizophrenia. Psychol Med 32(2):277-286, 2002.
21. Dazzan P, Kravariti E, Fearon P, Murray RM: Is the development of schizophrenia predictable? In: Early Clinical Intervention and Prevention in Schizophrenia. Edited by Stone WS, Faraone SV, Tsuang MT. Totowa (New Jersey), Humana Press, 2004, pp 225-252.
22. Dworkin RH, Bernstein G, Kaplansky LM, Lipsitz JD, Rinaldi A, Slater SL, Cornblatt BA, Erlenmeyer-Kimling L: Social competence and positive and negative symptoms: A longitudinal study of children and adolescents at risk for schizophrenia and affective disorder. Am J Psychiatry 148(9):1182-1188, 1991.
23. Dworkin RH, Cornblatt BA, Friedmann R, Kaplansky LM, Lewis JA, Rinaldi A, Shilliday C, Erlenmeyer-Kimling L: Childhood precursors of affective versus social deficits in adolescents at risk for schizophrenia. Schizophr Bull 19:563-577, 1993.
24. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR: Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 98(12):6917-6922, 2001.
25. Erlenmeyer-Kimling L: Neurobehavioral deficits in offspring of schizophrenic parents: Liability indicators and predictors of illness. Am J Med Genet (Neuropsychiatr Genet) 97:65-71, 2000.
26. Erlenmeyer-Kimling L, Cornblatt B: High-risk research in schizophrenia: A summary of what has been learned. J Pyschiatr Res 21:401-411, 1987.
27. Erlenmeyer-Kimling L, Cornblatt B, Friedman D, Marcuse Y, Rutschmann J, Simmens S, Devi F: Neurological, electrophysiological, and attentional deviations in children at risk for schizophrenia. In: Schizophrenia as a Brain Disease. Edited by Henn FA, Nasrallah HA. New York, Oxford University Press, 1982, pp 61-98.
28. Erlenmeyer-Kimling L, Cornblatt BA: Summary of attentional findings in the New York High-Risk Project. J Psychiatr Res 26(4):405-426, 1992.
29. Erlenmeyer-Kimling L, Rock D, Roberts SA, Janal M, Kestenbaum C, Cornblatt B, Adamo UH, Gottesman II: Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: The New York High-Risk Project. Am J Psychiatry 157(9):1416-1422, 2000.
30. Faraone SV, Glatt SJ, Taylor L: The genetic basis of schizophrenia. In: Early Clinical Intervention and Prevention in Schizophrenia. Edited by Stone WS, Faraone SV, Tsuang MT. Totowa (New Jersey), Humana Press, 2004, pp 3-25.
31. Faraone SV, Green AI, Seidman LJ, Tsuang MT: "Schizotaxia": Clinical implications and new directions for research. Schizophr Bull 27:1-18, 2001.
32. Faraone SV, Kremen WS, Lyons MJ, Pepple JR, Seidman LJ, Tsuang MT: Diagnostic accuracy and linkage analysis: How useful are schizophrenia spectrum phenotypes? Am J Psychiatry 152: 1286-1290, 1995a.
33. Faraone SV, Seidman LJ, Kremen WS, Kennedy D, Makris N, Caviness VS, Goldstein J, Tsuang MT: Structural brain abnormalities among relatives of patients with schizophrenia: Implications for linkage studies. Schizophr Res 60(2-3):125-140, 2003.
34. Faraone SV, Seidman LJ, Kremen WS, Pepple JR, Lyons MJ, Tsuang MT: Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A diagnostic efficiency analysis. J Abnorm Psychol 104:286-304, 1995b.
35. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT: Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A four-year follow-up study. J Abnorm Psychol 108:176-181, 1999.
36. Freedman LR, Rock D, Roberts SA, Cornblatt BA, Erlenmeyer-Kimling L: The New York High-Risk Project: Attention, anhedonia, and social outcome. Schizophr Res 30:1-9, 1998.
37. Goldstein JM, Seidman LJ, Goodman JM, Koren D, Makris N, Kennedy DN, Weintraub S, Caviness VS, Tsuang MT: The impact of sex on cognition and structural brain MRI in schizophrenia. Biol Psychiatry 39:575, 1996.
38. Gottesman II: Schizophrenia Genesis: The Origin of Madness. New York, Freeman, 1991.
39. Gottesman II: Psychopathology through a life-span genetic prism. Am Psychol 56:864-878, 2001.
40. Gottesman II, Gould TD: The endophenotype concept in psychiatry: Etymology and strategic in tentions. Am J Psychiatry 160:636-645, 2003.
41. Gottesman II, Shields J: Contributions of twin studies to perspectives on schizophrenia. In: Progress in Experimental Personality Research. Edited by Maher, B.A. New York, Academic Press, 1966.
42. Gottesman II, Shields J: Schizophrenia and Genetics: A Twin Study Vantage Point. New York, Academic Press, 1972.
43. Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia. Am J Psychiatry 153:321-330, 1996.
44. Green MF, Braff DL: Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications. Biol Psychiatry 49:374-384, 2001.
45. Green MF, Kern RS, Braff DL, Mintz J: Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophr Bull 26:119-136, 2000.
46. Heinrichs RW, Zakzanis KK: Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology 12:426-445, 1998.
47. Hodges A, Byrne M, Grant E, Johnstone E: People at risk of schizophrenia: Sample characteristics of the first 100 subjects. Br J Psychiatry 174:547-553, 1999.
48. Kendler KS: Twin studies of psychiatric illness: An update. Arch Gen Psychiatry 58(11):1005-1014, 2001.
49. Keshavan MS, Dick E, Mankowski I, Harenski K, Montrose DM, Diwadkar V, DeBellis M: Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. Schizophr Res 58:173-183, 2002a.
50. Keshavan MS, Montrose DM, Pierri JN, Dick EL, Rosenberg D, Talagala L, Sweeney JA: Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: Preliminary studies. Prog Neuropsychopharmacol Biol Psychiatry 21: 1285-1295, 1997.
51. Keshavan MS, Siwadkar VA, Spencer SM, Harenski KA, Luna B, Sweeney JA: A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents. Prog Neuropsychopharmacol Biol Psychiatry 26:1143-1149, 2002b.
52. Kremen WS, Hoff AL: Neurocognitive deficits in the biological relatives of individuals with schizophrenia. In: Early Clinical Intervention and Prevention with Schizophrenia. Edited by Stone WS, Faraone SV, Tsuang MT. Totowa (New Jersey), Humana Press, 2004, pp 133-158.
53. Kremen WS, Seidman LJ, Pepple JR, Lyons MJ, Tsuang MT, Faraone SV: Neuropsychological risk indicators for schizophrenia: A review of family studies. Schizophr Bull 20:103-119, 1994.
54. Lawrie SM, Byrne M, Miller P, Hodges A, Clafferty RA, Cunningham Owens DG, Johnstone EC: Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry 178:524-530, 2001a.
55. Lawrie SM, Whalley HC, Abukmeil SS, Kestelman JN, Donnelly L, Miller P, Best JJ, Owens DG, Johnstone EC: Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biol Psychiatry 49(10):811-823, 2001b.
56. Lawrie SM, Whatley H, Kesteiman JN, Abukmeil SS, Byrne M, Hodges A, Rimmington JE, Best JJK, Owens DGC, Johnstone EC: Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet 353:30-33, 1999.
57. Ledingham J: Recent developments in high-risk research. In: Advances in Clinical Child Psychology. Edited by Lahey BB, Kazdin AE. New York, Plenum Press, 1990, pp 91-137.
58. Lifshitz M, Kugelmass S, Karov M: Perceptual-motor and memory performance of high-risk children. Schizophr Bull 11:74-84, 1985.
59. Marcus J, Hans SL, Nagler S, Auerbach JG, Mirsky AF, Aubrey A: Review of the NIMH Israeli Kibbutz-City Study and the Jerusalem Infant Development Study. Schizophr Bull 13:425-438, 1987.
60. Marenco S, Weinberger DR: Obstetric risk factors for schizophrenia and their relationship to genetic predisposition: Following Ariadne's double-stranded thread through early development. In: Early Clinical Intervention and Prevention in Schizophrenia. Edited by Stone WS, Faraone SV, Tsuang MT. Totawa (New Jersey), Humana Press, 2004, pp 43-71.
61. Meehl PE: Schizotaxia, schizotypy, schizophrenia. Am Psychol 17:827-838, 1962.
62. Meehl PE: Schizotaxia revisited. Arch Gen Psychiatry 46:935-944, 1989.
63. Miller P, Byrne M, Hodges A, Lawrie SM, Owens DGC, Johnstone EC: Schizotypal components in people at high risk of developing schizophrenia: Early findings from the Edinburgh High-Risk Study. Br J Psychiatry 180:179-184, 2002.
64. Mirnics K, Pevsner J: Progress in the use of microarray technology to study the neurobiology of disease. Nat Neurosci 7:1-6, 2004.
65. Mirsky AF, Duncan CC: A neuropsychological perspective on vulnerability to schizophrenia: Lessons from high-risk studies. In: Early Clinical Intervention and Prevention in Schizophrenia. Edited by Stone WS, Faraone SV, Tsuang MT. Totowa (New Jersey), Humana Press, 2004, pp 115-132.
66. Moldin SO, Gottesman II, Erlenmeyer-Kimling L, Cornblatt BA: Psychometric deviance in offspring at risk for schizophrenia: I. Initial delineation of a distinct subgroup. Psychiatry Res 32:297-310, 1990.
67. Neale J: Information processing and vulnerability: High-risk research. In: Preventive Intervention in Schizophrenia: Are We Ready? Edited by Goldstein MJ. Washington (DC), DHHS Pub. No. (SDM) 82-1111 Government Printing Office, 1982, pp 78-89.
68. Neuenterlein KH, Dawson ME: Information processing and attentional functioning in the developmental course of schizoprenic disorders. Schizophr Bull 10:160-203, 1984.
69. Niemi LT, Suvisaari JM, Tuulio-Henriksson A, Lonnqvist JK: Childhood developmental abnormalities in schizophrenia: Evidence from high-risk studies. Schizophr Res 60:239-258, 2003.
70. Olin S-CS: Assessing the predictive value of teacher reports in a high-risk sample for schizophrenia. Schizophr Res 16:53-66, 1995.
71. Rado S, John RS, Mednick SA: Dynamics and classification of disordered behavior. Am J Psychiatry 110:406-416, 1953.
72. Rado S: Theory and therapy. The theory of schizotypal organization and its application to the treatment of decompensated schizotypal behavior. In: The Outpatient Treatment of Schizophrenia. Edited by Scher SC, Davis HR. New York, Grune & Stratton, 1960, pp 87-101.
73. Rajarethinam R, Sahni S, Rosenberg DR, Keshavan MS: Reduced superior temporal gyrus volume in young offspring of patients with schizophrenia. Am J Psychiatry 161:1121-1124, 2004.
74. Rutschmann J, Cornblatt BA, Erlenmeyer-Kimling L: Auditory recognition memory in adolescents at risk for schizophrenia: Report on a verbal continuous recognition task. Psychiatry Res 3:151-161, 1980.
75. Ryan MCM, Thakore JH: Physical consequences of schizophrenia and its treatment: The metabolic syndrome. Life Sci 71:239-257, 2002.
76. Schreiber H, Baur-Seack K, Kornhuber HH, Wallner B, Friedrich JM, De Winter IM, Born J: Brain morphology in adolescents at genetic risk for schizophrenia assessed by qualitative and quantitative magnetic resonance imaging. Schizophr Res 40:81-84, 1999.
77. Schreiber H, Stolz-Born G, Heinrich H, Kornhuber HH, Born J: Attention, cognition, and motor perseveration in adolescents at genetic risk for schizophrenia and control subjects. Psychiatry Res 44(2):125-140, 1992.
78. Seidman LJ: Schizophrenia and brain dysfunction: An integration of recent neurodiagnostic findings. Psychol Bull 94:195-238, 1983.
79. Seidman LJ, Oscar-Berman M, Kalinowski AG, Ajilor O, Kremen WS, Faraone SV, Tsuang MT: Experimental and clinical neuropsychological measures of prefrontal dysfunction in schizophrenia. Neuropsychology 9:1-10, 1995.
80. Seidman LJ, Pantelis C, Keshavan MS, Faraone SV, Goldstein JM, Horton NJ, Makris N, Falkai P: A review and a new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: A MRI morphometric family study of the parahippocampal gyrus. Schizophr Bull 29: 803-808, 2003.
81. Seidman LJ, Van Manen KJ, Turner WM, Gamser DM, Faraone SV, Goldstein JM, Tsuang MT: The effects of increasing resource demand on vigilance performance in adults with schizophrenia or developmental attentional/learning disorders: A preliminary study. Schizophr Res 34(1-2):101-112, 1998.
82. Seidman LJ, Wencel HE: Genetically mediated brain abnormalities in schizophrenia. Curr Psychiatry Rep 5(2):135-144, 2003.
83. Seidman LJ, Wencel HE, McDonald C, Murray RM, Tsuang MT: Neuroimaging studies of nonpsychotic first-degree relatives of people with schizophrenia. In: Early Clinical Intervention and Prevention in Schizophrenia. Edited by Stone WS, Faraone SV, Tsuang MT. Totowa (New Jersey), Humana Press, 2004, pp 179-210.
84. Siever LJ, Davis KL: The pathophysiology of schizophrenia disorders: Perspectives from the spectrum. Am J Psychiatry 161:398-413, 2004.
85. Squires-Wheeler E, Friedman D, Ammunger GP: Negative and positive dimensions of schizotypal personality disorder. J Personality Disord 11:285-300, 1997.
86. Stone WS, Faraone SV, Seidman LJ, Green AI, Wojcik JD, Tsuang MT: Concurrent validation of schizotaxia: A pilot study. Biol Psychiatry 50(6): 434-440, 2001.
87. Stone WS, Glatt SJ, Faraone SV: The biology of schizotaxia. In: Early Clinical Intervention and Prevention of Schizophrenia. Edited by Stone WS, Faraone SV, Tsuang MT. Totowa (New Jersey), Humana Press, 2004, pp 339-353.
88. Tibbo P, Hanstock C, Valiakalayil A, Allen P: 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia. Am J Psychiatry 161:1116-1118, 2004.
89. Tsuang MT, Faraone SV: The case for heterogeneity in the etiology of schizophrenia. Schizophr Res 17:161-175, 1995.
90. Tsuang MT, Gilbertson MW, Faraone SV: Genetic transmission of negative and positive symptoms in the biological relatives of schizophrenics. In: Positive vs. Negative Schizophrenia. Edited by Marneros A, Tsuang MT, Andreasen N. New York, Springer-Verlag, 1991, pp 265-291.
91. Tsuang MT, Stone WS, Faraone SV: Schizophrenia: A review of genetic studies. Harv Rev Psychiatry 7:185-207, 1999a.
92. Tsuang MT, Stone WS, Faraone SV: Towards reformulating the diagnosis of schizophrenia. Am J Psychiatry 147:1041-1050, 2000.
93. Tsuang MT, Stone WS, Seidman LJ, Faraone SV, Zimmet S, Wojcik J, Kelleher J, Green AI: Treatment of nonpsychotic relatives of patients with schizophrenia: Four case studies. Biol Psychiatry 41:1412-1418, 1999b.
94. Tsuang MT, Stone WS, Tarbox SI, Faraone SV: An integration of schizophrenia with schizotypy: Identification of schizotaxia and implications for research on treatment and prevention. Schizophr Res 54(1-2):169-175, 2002.
95. Vartiovaara A, Makela S, Pykalainen R: Effects of parental schizophrenia on children's mental health. Psychiatria Fennica 21:87-103, 1990.
96. Voglmeier MM, Seidman LJ, Niznikiewicz MA, Dickey CC, Shenton ME, McCarley RW: Verbal and nonverbal neuropsychological test performance in subjects with schizotypal personality disorder. Am J Psychiatry 157:787-793, 2000.
97. Wechsler D: Wechsler Memory Scale, 3rd ed. San Antonio (Texas), The Psychological Corporation, Harcourt Brace & Company, 1997.
98. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669, 1987.
99. Weinberger DR: Schizophrenia as a neurodevelopmental disorder: A review of the concept. In: Schizophrenia. Edited by Hirsch SR, Weinberger DR. London, Blackwood Press, 1994.
100. Weinberger DR: Neurodevelopmental perspectives on schizophrenia. In: Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 1171-1183.
101. Wolf LE: Wisconsin card sorting deficits in the offspring of schizophrenics in the New York High-Risk Project. Schizophr Res 57:173-182, 2002.
102. Zornberg GL, Buka SL, Tsuang MT: Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: A 19-year longitudinal study. Am J Psychiatry 157(2):196-202, 2000.